{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:21:03Z","timestamp":1790968863213,"version":"4.1.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004925","name":"Texas Health and Human Services Commission","doi-asserted-by":"publisher","award":["1H79TI083288"],"award-info":[{"award-number":["1H79TI083288"]}],"id":[{"id":"10.13039\/100004925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Opioid use disorder (OUD) is associated with significant morbidity and mortality; however, research on physical and mental health comorbidities and health-related quality of life (HRQoL) among people taking medication for OUD (MOUD) and living in recovery residences is sparse. We investigated the prevalence of comorbidities and examined which EQ-5D-5L HRQoL dimensions are most affected by these comorbidities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were collected from 358 residents living in 14 Texas-based recovery residences from April 2021 to June 2023. The EQ-5D-5L descriptive system comprises five dimensions (mobility, self-care, usual activities, pain\/discomfort, anxiety\/depression). Each dimension has five levels of perceived problems, dichotomized into \u201cNo problems\u201d (level 1) and \u201cAny problems\u201d (levels 2\u20135) for analyses. Cross-sectional analyses of residents' characteristics, comorbidities (categorized as mental health disorders or association with major body systems), and EQ-5D-5L dimensions were conducted using Chi-squared or Student <jats:italic>t<\/jats:italic>-tests. Multivariable logistic regression models were used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean [SD] age of residents was 36.0 [8.9]. Most residents were non-Hispanic White (68.7%), male (59.7%), unemployed (66.3%), and engaged in polysubstance use (75.4%). The most frequently reported comorbidities were mental health (26.5%), respiratory (26.3%), neurological (19.3%), cardiovascular (18.2%), and musculoskeletal (17.0%) disorders. The most reported HRQoL problems were anxiety\/depression (75.8%) and pain\/discomfort (53.2%). In the unadjusted regression models, all comorbidities, except mental health (negative association) and digestive (no association) disorders, were positively associated with HRQoL problems. The usual activities dimension was the most affected by comorbidities, followed by mobility and pain\/discomfort. Increasing age was positively associated with cardiovascular disorders (aOR = 1.06; 95% CI = 1.03\u20131.10), musculoskeletal disorders (aOR = 1.03; 95% CI = 1.00\u20131.06), mobility problems (aOR = 1.05; 95% CI = 1.01\u20131.09), and pain\/discomfort problems (aOR = 1.02; 95% CI = 1.00\u20131.05). Illicit drug use was positively associated with mobility problems (aOR = 3.36; 95% CI = 1.20\u20139.45). Neurological (aOR = 2.71; 95% CI = 1.38\u20135.33) and musculoskeletal (aOR = 2.57; 95% CI = 1.25\u20135.29) disorders were positively associated with pain\/discomfort problems. MOUD duration was negatively associated with mental health disorders (aOR = 0.14; 95% CI = 0.08\u20130.22) but not HRQoL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Comorbidities significantly predict HRQoL among individuals with OUD. Our findings highlight the need for an integrated care model to treat OUD and comorbidities to sustain recovery and improve health and HRQoL.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1412934","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T06:19:26Z","timestamp":1731997166000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Characteristics and quality of life of people living with comorbid disorders in substance use recovery residences"],"prefix":"10.3389","volume":"12","author":[{"given":"Elizabeth O.","family":"Obekpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl A.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn R.","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Ganduglia","family":"Cazaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Shelton","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"108350","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B2","unstructured":"Drug Overdose Deaths\n          \n          2022"},{"key":"B3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jval.2016.04.010","article-title":"Measuring health and broader wellbeing benefits in the context of opiate dependence: The psychometric performance of the ICECAP-A and the EQ-5D-5L","volume":"19","author":"Goranitis","year":"2016","journal-title":"Value Health."},{"key":"B4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11136-010-9732-3","article-title":"Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment","volume":"20","author":"De Maeyer","year":"2011","journal-title":"Qual Life Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jsat.2017.01.019","article-title":"Quality of life as an outcome of opioid use disorder treatment: a systematic review","volume":"76","author":"Bray JW Aden","year":"2017","journal-title":"J Subst Abuse Treat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12955-022-01935-9","article-title":"Health-related quality of life in outpatients with substance use disorder: evolution over time and associated factors","volume":"20","author":"Simirea","year":"2022","journal-title":"Health Qual Life Outcomes."},{"key":"B7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12955-015-0231-7","article-title":"Quality of life improved following in-patient substance use disorder treatment","volume":"13","author":"Pasareanu","year":"2015","journal-title":"Health Qual Life Outcomes"},{"key":"B8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12955-017-0781-y","article-title":"Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use","volume":"15","author":"Adan","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"B9","first-page":"44","article-title":"The case for considering quality of life in addiction research and clinical practice","volume":"6","author":"Laudet","year":"2011","journal-title":"Addict Sci Clin Pract."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s11136-015-0947-1","article-title":"Assessing quality of life in Crohn's disease: development and validation of the Crohn's Life Impact Questionnaire (CLIQ)","volume":"24","author":"Wilburn","year":"2015","journal-title":"Qual Life Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1053\/apmr.2000.20621","article-title":"Health-related quality of life outcomes measures","volume":"81","author":"Andresen","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"key":"B12","doi-asserted-by":"publisher","first-page":"108602","DOI":"10.1016\/j.drugalcdep.2021.108602","article-title":"The phenomics and genetics of addictive and affective comorbidity in opioid use disorder","volume":"221","author":"Freda","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B13","doi-asserted-by":"publisher","first-page":"109778","DOI":"10.1016\/j.drugalcdep.2023.109778","article-title":"The cost of opioid use disorder-related conditions in Medicare","volume":"244","author":"Mark","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"B14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.drugalcdep.2019.01.031","article-title":"Polydrug use disorders in individuals with opioid use disorder","volume":"198","author":"Hassan","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"B15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jamapsychiatry.2020.3554","article-title":"Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable Mendelian randomization analysis","volume":"78","author":"Rosoff","year":"2021","journal-title":"Arch Gen Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/09540261.2018.1514369","article-title":"Comorbid chronic pain and opioid use disorder: Literature review and potential treatment innovations","volume":"30","author":"Speed","year":"2018","journal-title":"Int. Rev. Psychiat."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1161\/CIR.0000000000001007","article-title":"Opioid use and its relationship to cardiovascular disease and brain health: A presidential advisory from the American Heart Association","volume":"144","author":"Chow","year":"2021","journal-title":"Circulation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0220216","DOI":"10.1371\/journal.pone.0220216","article-title":"An updated analysis of opioids increasing the risk of fractures","volume":"15","author":"Yue","year":"2020","journal-title":"PLoS ONE"},{"key":"B19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2013.01.010","article-title":"Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample","volume":"132","author":"Katz","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"B20","unstructured":"Common Comorbidities With Substance Use Disorders Research Report\n          \n          2020"},{"key":"B21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/SAR.S85667","article-title":"Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates","volume":"6","author":"Boscarino","year":"2015","journal-title":"Subst Abuse Rehabil."},{"key":"B22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.11138\/ccmbm\/2016.13.2.097","article-title":"Bone pain mechanism in osteoporosis: a narrative review","volume":"13","author":"Mattia","year":"2016","journal-title":"Clin Cases Miner Bone Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/ADM.0000000000000260","article-title":"Alcohol, cannabis, and opioid use disorders, and disease burden in an integrated health care system","volume":"11","author":"Bahorik","year":"2017","journal-title":"J Addict Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF03391702","article-title":"Substance use and associated health conditions throughout the lifespan","volume":"35","author":"Schulte","year":"2014","journal-title":"Public Health Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"E157","DOI":"10.5888\/pcd16.190169","article-title":"Opioid-related hospitalization and its association with chronic diseases: findings from the national inpatient sample, 2011-2015","volume":"16","author":"Rajbhandari-Thapa","year":"2019","journal-title":"Prev Chronic Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction."},{"key":"B27","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S2215-0366(22)00335-2","article-title":"Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in Czechia","volume":"9","author":"Form\u00e1nek","year":"2022","journal-title":"Lancet Psychiat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0140-6736(09)60009-X","article-title":"Alcohol-use disorders","volume":"373","author":"Schuckit","year":"2009","journal-title":"Lancet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"108493","DOI":"10.1016\/j.drugalcdep.2020.108493","article-title":"Independent effects of entering recovery as a young versus older adult on long-term functioning and quality of life: Results from a U. S. national study of recovering persons","volume":"219","author":"Kelly","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/ADM.0000000000000280","article-title":"Physical and mental health comorbidities associated with primary care visits for substance use disorders","volume":"11","author":"Lagisetty","year":"2017","journal-title":"J Addict Med."},{"key":"B31","unstructured":"Drug Overdose Death Rates\n          \n          2024"},{"key":"B32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/08897077.2021.1932698","article-title":"Multidisciplinary treatment of opioid use disorder in primary care using the collaborative care model","volume":"43","author":"Brackett","year":"2022","journal-title":"Subst Abuse."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1001\/jama.286.14.1715","article-title":"Integrating primary medical care with addiction treatment: a randomized controlled trial","volume":"286","author":"Weisner","year":"2001","journal-title":"JAMA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1525-1497.2003.10601.x","article-title":"Effect of primary medical care on addiction and medical severity in substance abuse treatment programs","volume":"18","author":"Friedmann","year":"2003","journal-title":"J Gen Intern Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s11904-023-00667-9","article-title":"Integrated care models: HIV and substance use","volume":"20","author":"Hill","year":"2023","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"108638","DOI":"10.1016\/j.jsat.2021.108638","article-title":"The role of recovery housing during outpatient substance use treatment","volume":"133","author":"Mericle","year":"2022","journal-title":"J Subst Abuse Treat."},{"key":"B37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/02791072.2010.10400705","article-title":"What did we learn from our study on sober living houses and where do we go from here?","volume":"42","author":"Polcin","year":"2010","journal-title":"J Psychoactive Drugs."},{"key":"B38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1037\/a0030948","article-title":"A wraparound treatment engagement intervention for homeless veterans with co-occurring disorders","volume":"10","author":"Smelson","year":"2013","journal-title":"Psychol Serv."},{"key":"B39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/02791072.2008.10400625","article-title":"clean and sober place to live: Philosophy, structure, and purported therapeutic factors in sober living houses","volume":"40","author":"Polcin","year":"2008","journal-title":"J Psychoactive Drugs."},{"key":"B40","unstructured":"An Introduction and Membership Invitation from the National Association of Recovery Residences\n          \n          2011"},{"key":"B41","unstructured":"EQ-5D-5L User Guide: Basic Information on How to Use the EQ-5D-5L Instrument\n          \n          2019"},{"key":"B42","unstructured":"Center for Mental Health Services NOMs Client-Level Measures for Discretionary Programs Providing Direct Services: Services Tool for Adult Programs\n          \n          2019"},{"key":"B43","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction."},{"key":"B44","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1007\/978-94-007-0753-5_1494","article-title":"Internal consistency reliability","volume-title":"Encyclopedia of Quality of Life and Wellbeing Research.","author":"Revicki","year":"2014"},{"key":"B45","volume-title":"Stata Statistical Software: Release 16","year":"2019"},{"key":"B46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/15504263.2018.1518553","article-title":"A review of integrated care for concurrent disorders: cost effectiveness and clinical outcomes","volume":"15","author":"Karapareddy","year":"2019","journal-title":"J Dual Diagn."},{"key":"B47","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2105\/AJPH.86.7.973","article-title":"Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care","volume":"86","author":"Dickey","year":"1996","journal-title":"Am J Public Health."},{"key":"B48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF02287493","article-title":"Utilization of services for mentally ill chemically abusing patients discharged from residential treatment","volume":"26","author":"Maynard","year":"1999","journal-title":"J Behav Health Serv Res."},{"key":"B49","unstructured":"Recovery Housing: Best Practices and Suggested Guidelines.\n          \n          2023"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2105\/AJPH.2005.070839","article-title":"Communal housing settings enhance substance abuse recovery","volume":"96","author":"Jason","year":"2006","journal-title":"Am J Public Health."},{"key":"B51","first-page":"104","article-title":"Is the therapeutic community an evidence-based treatment? What the evidence says","volume":"31","author":"De Leon","year":"2010","journal-title":"Therap Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.copsyc.2018.12.020","article-title":"Comorbidity of opioid- and anxiety-related symptoms and disorders","volume":"30","author":"Langdon","year":"2019","journal-title":"Curr Opin Psychol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e15309","DOI":"10.7759\/cureus.15309","article-title":"Prevalence and trends of opioid use in patients with depression in the United States","volume":"13","author":"Tumenta","year":"2021","journal-title":"Cur\u0113us"},{"key":"B54","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/ajad.12637","article-title":"Chronic pain and opioid abuse: Factors associated with health-related quality of life","volume":"26","author":"Jones","year":"2017","journal-title":"Am J Addict."},{"key":"B55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.yebeh.2019.01.035","article-title":"Spirituality and quality of life in epilepsy and other chronic neurological disorders","volume":"93","author":"Giovagnoli","year":"2019","journal-title":"Epilepsy Behav."},{"key":"B56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1212\/WNL.55.5.629","article-title":"Migraine, quality of life, and depression: a population-based case-control study","volume":"55","author":"Lipton","year":"2000","journal-title":"Neurology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semarthrit.2014.05.001","article-title":"The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis","volume":"44","author":"Matcham","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med."},{"key":"B59","first-page":"207","article-title":"Alcoholic Myopathy: Pathophysiologic mechanisms and clinical implications","volume":"38","author":"Simon","year":"2017","journal-title":"Alcohol Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jpsychires.2020.09.032","article-title":"Effect of chronic cocaine use on fine motor coordination tested during ophthalmic vitreoretinal simulated performance","volume":"132","author":"Roizenblatt","year":"2021","journal-title":"J Psychiat Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1532-5415.2005.00571.x","article-title":"Benzodiazepine use and physical disability in community-dwelling older adults","volume":"54","author":"Gray","year":"2006","journal-title":"J Am Geriatr Soc."},{"key":"B62","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ncl.2011.05.004","article-title":"Neurologic manifestations of chronic methamphetamine abuse","volume":"29","author":"Rusyniak","year":"2011","journal-title":"Neurol Clin."},{"key":"B63","first-page":"155","article-title":"Impact of smoking on speed and coordination of upper limb movement","volume":"6","author":"Kumar","year":"2014","journal-title":"Addict Sci Clin Pract."},{"key":"B64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths- United States, 2013-2019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0924-977X(01)80483-1","article-title":"Subjective quality of life in opiate-dependent patients before admission after six months and one-year participation in methadone program","volume":"59","author":"Habrat","year":"2002","journal-title":"Przegl Lek."},{"key":"B66","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13011-020-00286-2","article-title":"Health-related quality of life of long-term patients receiving opioid agonist therapy: A nested prospective cohort study in Norway","volume":"15","author":"Aas","year":"2020","journal-title":"Subst Abuse Treat Prev Policy."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1284192","DOI":"10.3389\/fpubh.2023.1284192","article-title":"Health-related quality of life and recovery capital among recovery residents taking medication for opioid use disorder in Texas","volume":"11","author":"Obekpa","year":"2023","journal-title":"Public Health Front"},{"key":"B68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/10826080701681473","article-title":"Recovery capital as prospective predictor of sustained recovery, life satisfaction, and stress among former poly-substance users","volume":"43","author":"Laudet","year":"2008","journal-title":"Subst Use Misuse."},{"key":"B69","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/ADM.0000000000001206","article-title":"Situational confidence and recovery capital among recovery residents taking medications for opioid use disorder in Texas","volume":"17","author":"Obekpa","year":"2023","journal-title":"J Addict Med."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1412934\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T06:19:34Z","timestamp":1731997174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1412934\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":69,"alternative-id":["10.3389\/fpubh.2024.1412934"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1412934","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"article-number":"1412934"}}